(NASDAQ: ALEC) Alector's forecast annual revenue growth rate of -16.02% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 65.42%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.4%.
Alector's revenue in 2025 is $100,558,000.On average, 3 Wall Street analysts forecast ALEC's revenue for 2025 to be $991,453,395, with the lowest ALEC revenue forecast at $1,981,718, and the highest ALEC revenue forecast at $1,981,717,760. On average, 3 Wall Street analysts forecast ALEC's revenue for 2026 to be $1,265,326,790, with the lowest ALEC revenue forecast at $357,700,056, and the highest ALEC revenue forecast at $1,981,717,760.
In 2027, ALEC is forecast to generate $7,209,984,640 in revenue, with the lowest revenue forecast at $3,711,757,364 and the highest revenue forecast at $10,708,311,002.